LEXINGTON, Mass., June 1, 2012 (GLOBE NEWSWIRE) -- Agenus Inc. (Nasdaq:AGEN) invites investors and the general public to its 2012 Annual Shareholders Meeting at 5:00 p.m. ET on Wednesday, June 13th. The meeting will be held at the company's headquarters at 3 Forbes Road, Lexington, MA 02421. Registration for attendees starts at 4:30 p.m. ET.
A live webcast will be accessible from the company's website at www.agenusbio.com/webcast/ and will be archived and available for replay approximately two hours after the meeting.
Agenus Inc. is a biotechnology company working to develop treatments for cancers and infectious diseases. The company is focused on immunotherapeutic products based on strong platform technologies with multiple product candidates advancing through the clinic, including several product candidates that have advanced into late-stage clinical trials through corporate partners. Between Agenus and its partners, 18 programs are in clinical development. For more information, please visit www.agenusbio.com.
The Agenus logo is available at http://www.globenewswire.com/newsroom/prs/?pkgid=8187
CONTACT: Media and Investor Contact: Jonae R. Barnes Vice President Investor Relations and Corporate Communications email@example.com 781-674-4538 Office 617-818-2985 Cell
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Press Release Service provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates Bots go here